Blue Jet Healthcare Limited (BLUEJET) — Board Meeting Announcement

StockFin.ai Try Free →

📢 Key Event
Board approved audited FY2026 results, final dividend, fund-raising proposal, and scheduled EGM.

🔄 What Changed
Final dividend of ₹1.2 per share; fund-raising up to ₹10,000 million; re-appointment of internal auditors.

🔮 What's Next
Fund-raising to be executed via public issue, preferential issue, or private placement subject to shareholder and regulatory approvals; EGM set for June 17, 2026.

💡 Investor Takeaway
The dividend signals confidence in profitability, while the fund-raising may dilute shares if executed, requiring investor monitoring of capital structure impact.

Blue Jet Healthcare announced the outcome of its May 25, 2026 board meeting, approving audited standalone financial results for Q4 and FY2026, a final dividend of ₹1.2 per share (60% of face value), re-appointment of internal auditors, and a fund-raising proposal up to ₹10,000 million via securities. It also scheduled an Extraordinary General Meeting for June 17, 2026 to seek shareholder approval for the fund-raising and other matters. The board highlighted strong revenue growth to ₹3,404.45 million in Q4 and profitability, while the fund-raising aims to support expansion without immediate dilution details.

📄 View Original Announcement (PDF)

📊 Stock Analysis — BLUEJET ✨ Ask AI About This

About Blue Jet Healthcare Limited (BLUEJET)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹7,465.95 Cr P/E: 25.4

View full BLUEJET stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Blue Jet Healthcare Limited (BLUEJET) — Board Meeting Announcement

About Blue Jet Healthcare Limited (BLUEJET)

Recent Announcements from Blue Jet Healthcare Limited